Likewise, tumor-associated CD103+CD4 TRM have been described to be highly enriched for tumor-specific T cells (76) and suppress tumor growth through the secretion of TNF-α and IFN-γ or direct killing of tumor cells (77, 78). This evidence concerns the gene CD4 and neoplasm.